Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Okines

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Breast Cancer Research and Treatment|September 20, 2019
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experienceNicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal MetastasisAmanda Fitzpatrick, Marjan Iravani, Adam Mills, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Breast Cancer Research and Treatment|May 14, 2024
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective studyMatilde Corianò, Chiara Tommasi, Anh Thi Lan Dinh, et al.
European Heart Journal. Acute Cardiovascular Care|October 13, 2022
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmiasSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
The Journal of Molecular Diagnostics : JMD|March 10, 2015
Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissuesShenli Zhang, Iain B Tan, Nur S Sapari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast CancerMaria Coakley, Guillermo Villacampa, Prithika Sritharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2025
HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast CancerVeronique Dieras, Giuseppe Curigliano, Miguel Martin, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|September 20, 2019
Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experienceNicolò Matteo Luca Battisti, Victoria True, Narda Chaabouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal MetastasisAmanda Fitzpatrick, Marjan Iravani, Adam Mills, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Breast Cancer Research and Treatment|May 14, 2024
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective studyMatilde Corianò, Chiara Tommasi, Anh Thi Lan Dinh, et al.
European Heart Journal. Acute Cardiovascular Care|October 13, 2022
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmiasSofie A Gevaert, Sigrun Halvorsen, Peter R Sinnaeve, et al.
The Journal of Molecular Diagnostics : JMD|March 10, 2015
Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissuesShenli Zhang, Iain B Tan, Nur S Sapari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast CancerMaria Coakley, Guillermo Villacampa, Prithika Sritharan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2025
HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast CancerVeronique Dieras, Giuseppe Curigliano, Miguel Martin, et al.
Pageof 4